3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Conditions
Colorectal Neoplasms
14
Carcinoma, Hepatocellular
5
Liver Neoplasms
3
Gastrointestinal Stromal Tumors
2
TAS 102
1
Neoplasms
1
Neoplasm Metastasis
1
Metastatic Colorectal Adenocarcinoma
1
Glioblastoma
1
Colonic Neoplasms
1
COVID-19
1
Advanced Gastrointestinal Stromal Tumor
1
Advanced Colorectal Carcinoma
1
Interventions
Surveys and Questionnaires
7
COVID-19 Vaccines
4
Surgical Procedures, Operative
3
Specimen Handling
3
Blood Specimen Collection
3
Pandemic Preparedness
2
Data Collection
2
BNT162 Vaccine
2
2019-nCoV Vaccine mRNA-1273
2
sinovac COVID-19 vaccine
1
regorafenib
1
heterologous prime boost COVID-19 vaccination
1
Telemedicine
1
Sorafenib
1
Serologic Tests
1
Patient Reported Outcome Measures
1
Meopa
1
Mastectomy, Segmental
1
High-Throughput Nucleotide Sequencing
1
Drug Therapy
1
Colonoscopy
1
Ad26COVS1
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
COVID-19
×
regorafenib
×
Clear all
NCT05594147
2023-11-07
ROCURS
Bayer
Completed
4,103 enrolled